The Food and Drug Administration (FDA) has approved a new emergency contraceptive, Ella or ulipristal acetate, which is effective at preventing pregnancy up to five days after contraceptive failure or unprotected sexual intercourse. In June, a panel of FDA expert medical advisors unanimously agreed that it is safe and effective in preventing the release of an egg. The drug inhibits or delays ovulation by diminishing the effects of progesterone, according to theFDA release.
According to the New York Times, Ella is more effective than Plan B, the "morning-after" pill available over the counter to women over the age of 17 in the United States. Plan B is only effective three days after contraceptive failure or unprotected sex. Side effects of Ella are similar to those of Plan B, including headache, nausea, abdominal pain, pain/discomfort during menstruation (dysmenorrhea), fatigue, and dizziness, according to WebMD Health News.
The drug, under the name EllaOne, is made by French company HRA Pharma. It is available with a prescription in Europe and is currently approved in 22 countries. Watson Pharmaceuticals Inc. will distribute Ella in the United States.
Anti-choice advocates argue that EllaOne is akin to mifepristone, which terminates existing pregnancies. According to Reuters, supporters of EllaOne agree that the drug is chemically similar to mifepristone, but one dose will not interfere with existing pregnancies. "There's just no evidence that it causes abortion," said Dr. Paul Fine, a Baylor College of Medicine professor and the medical director for Planned Parenthood in Houston and Southeast Texas.
Planned Parenthood has commended the FDA's decision. Planned Parenthood President Cecile Richards said, "Every woman deserves every option available to prevent an unplanned pregnancy, and there are many reasons why a woman may face the risk of unintended pregnancy, from failure or improper use of birth control to sexual assault," in a statement. "The FDA's approval of this new form of emergency contraception gives women one more option."
Media Resources: FDA Release; Feminist Newswire 6/16/10, 6/18/10; Los Angeles Times 8/13/10; New York Times 8/13/10; WebMD Health News 8/13/10; Planned Parenthood Press Release 8/13/10; Reuters 6/15/10
2/27/2015 This Bipartisan Bill Will Hold Colleges Accountable for Ending Campus Sexual Assault - A bipartisan bill aimed at holding colleges and universities accountable for rape and sexual assault cases was introduced in Congress yesterday, spearheaded by Senator Kirsten Gillibrand (D-NY).
Some of the Campus Accountability and Safety Act's key key provisions include a requirement of confidential reporting systems on colleges and universities, minimum training requirements for campus personnel, and stricter penalties for schools found to be in violation of Title IX or the Clery Act. . . .
2/26/2015 If This Bill Passes Federal Law Will Add Consent to Sex Ed Curriculums - Right now, federal law does not require health or sex education to include sexual assault prevention - but that could change with a new bill introduced by Senators Claire McCaskill (D-MO) and Tim Kaine (D-VA).
The Teach Safe Relationships Act of 2015, which was introduced earlier this month, would require all public secondary schools in the country to include teaching "safe relationship behavior" in order to help prevent domestic violence and sexual assault. . . .